Oncology
4 drugs are in development for Colorectal Cancer (CRC).
- Companies
- 3
- Clinical trials
- 24
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Colorectal Cancer (CRC) pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
About this indication
Colorectal Cancer (CRC) context
Oncology·MeSH: Colorectal Neoplasms (D015179)
Narrower concept of MeSH descriptor Colorectal Neoplasms
Prevalence
135.0 / 100K
Incidence
36.0 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Colorectal Cancer (CRC)?
BioSniper tracks 4 drugs in development for Colorectal Cancer (CRC) across 3 companies.
How many clinical trials target Colorectal Cancer (CRC)?
There are 24 clinical trials targeting Colorectal Cancer (CRC) tracked by BioSniper.
What is the prevalence of Colorectal Cancer (CRC)?
The estimated prevalence of Colorectal Cancer (CRC) is approximately 135.0 per 100,000 population.